PVALB and schizophrenia: In contrast, even in the absence of cellular-level (micro)structural changes, the potential overlap in GABAergic activity in parvalbumin-positive neurons to hippocampal dysfunction in schizophrenia and autism [88, 89] might be relevant to a common pathway.